New MISAT-Q Tool Enhances Migraine Treatment Satisfaction Insights
- MigraineMind
- Dec 16, 2025
- 1 min read
Research Summary
Researchers have developed the MISAT-Q questionnaire to gauge treatment satisfaction in migraine patients, as published in the Journal of Patient Reported Outcomes. This Spanish-language tool, created through a multicenter study in Spain, evaluates patients' experiences with acute and preventive migraine treatments. The 22-item questionnaire, refined from an initial 35 items, covers aspects such as side effects, treatment effectiveness, and overall satisfaction. Validation involved 209 patients, showing high reliability (Cronbach's alpha = 0.90) and strong validity. MISAT-Q effectively differentiates satisfaction levels based on migraine severity and treatment outcomes, offering clinicians a reliable means to assess patient satisfaction in treatment management.
Study Details
👥 Research Team: Gago-Veiga AB et al.
📚 Published In: J Patient Rep Outcomes
📅 Publication Date: 2025 Dec 15
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.